
Arla Foods Ingredients Showcases GLP-1 Companion Nutrition Range at Vitafoods Europe
Key Takeaways
- GLP-1 utilization in weight loss is rising, driven by broader access, emerging oral formulations, and declining costs, prompting demand for nutrient-dense, high-protein, easy-to-digest companion foods.
- Lean mass can represent up to 40% of weight lost on GLP-1 therapy versus ~25% with dieting or bariatric surgery, strengthening the rationale for complete-EAA protein strategies.
Arla Foods Ingredients introduced high-protein food and beverage concepts at Vitafoods Europe, targeting the fast-growing GLP-1 companion weight-management market.
At Vitafoods Europe, held from May 5–7 in Barcelona, Arla Foods Ingredients officially showcased its new portfolio of high-protein, nutrient-dense application concepts specifically developed for users of GLP-1 anti-obesity medications.1 This showcase of concepts comes as GLP-1 receptor agonists fundamentally re-shape the global weight management market, the company explains, highlighting data that indicates that among consumers actively trying to lose weight in 2025, 11% globally and 18% in the United States reported utilizing prescription weight loss medications. Industry adoption is projected to rise sharply as tablet formats emerge, global availability expands, and pricing declines, it adds.
Specialized Dairy Application Concepts
To address new physiological shifts in weight management, Arla Foods Ingredients introduced four specialized functional dairy prototypes. Developed around the company’s Nutrilac and Lacprodan BLG-100 whey protein solutions, these formulations deliver a complete essential amino acid profile to support muscle protein health. To manage gastrointestinal issues commonly associated with GLP-1 therapies, the concepts incorporate specific probiotics and cultures through a strategic partnership with bio-solutions supplier Novonesis.
The specific formats presented to Vitafoods attendees included:
- Fermented High-Protein Shot: Formulated with Nutrilac ProteinBoost, this low-fat, lactose-reduced shot provides 10g of protein per 70ml serving with no added sugar
- Fermented High-Protein Drinking Yogurt: This lactose-reduced beverage incorporates Nutrilac ProteinBoost and Nutrilac MFGM to deliver 20g of protein per 200ml serving
- Fermented High-Protein Spoonable Yogurt: This low-fat, lactose-reduced yogurt combines Nutrilac ProteinBoost, Nutrilac YO-7700, and Capolac milk minerals to supply 20g of protein and high calcium in a 120g serving
- Clear Water-Based Shot: Tailored for medical nutrition and ambient storage, this format utilizes Lacprodan BLG-100 to deliver 21g of protein per 100ml serving while remaining free from fat and sugar
Broadening High-Protein Food and Medical Nutrition Innovations
In addition to the core GLP-1 companion line, Arla Foods Ingredients expanded its Vitafoods launch to include two complementary texture and delivery innovations:
- AirBar Concept: An aerated protein bar solution utilizing Nutrilac PB-8420. The ingredient showcases high whipping capacity for stable air incorporation, resulting in a soft, fluffy texture that remains stable across its shelf life
- Ready-to-Stir Medical Nutrition Powders: Formulated with Lacprodan BLG-100 Acidic, these powder concepts deliver high protein concentrations with low viscosity, no bitterness, low astringency, and excellent solubility in both warm and cold liquids as well as food and drinks
Earlier this year,
Opportunities in the Weight Management Category
At the event, company representatives highlighted how GLP-1 therapies are forcing a fundamental rethink of weight management. While traditional interventions like calorie-restricted dieting or bariatric surgery typically cause lean muscle to comprise roughly 25% of total weight lost, Arla Foods cites clinical data showing that this can increase to as much as 40% with GLP-1 use. Furthermore, up to 76% of these consumers experience gastric discomforts such as stomach pain, nausea, constipation, and diarrhea.
Company leadership noted that the GLP-1 companion category represents a significant, untapped opportunity for dairy manufacturers. “Anti-obesity medications are creating a market for more nutrient-dense foods that are high in protein to protect lean muscle mass and are easy to digest,” stated Anne Widart, Chief Commercial Officer of Arla Foods Ingredients. “Featuring our specialty proteins, these new concepts can help manufacturers realize that potential. Delivering all the essential amino acids vital for muscle health, they also support gut comfort, and the small serving sizes and great taste appeal to smaller appetites.”
This article was created with assistance from AI. The content has been reviewed and edited by Erin McEvoy, Associate Editor. For more information on the extent and nature of AI usage, please contact us.
References
- Arla Foods Ingredients. Arla Foods Ingredients targets GLP-1 companion nutrition at Vitafoods Europe. April 15, 2026. Accessed May 19, 2026.
https://arla-foods-ingredients.prezly.com/arla-foods-ingredients-targets-glp-1-companion-nutrition-at-vitafoods-europe - McEvoy E. Arla Foods introduces BLG protein for flexible medical nutrition applications. February 3, 2026. Accessed May 19, 2026.
https://www.nutritionaloutlook.com/view/arla-foods-introduces-blg-protein-for-flexible-medical-nutrition-applications





